Pharmacogenetics by drug class
Every therapeutic class has its own pharmacogenetic story. Choose a class to see which medications have published genetic guidelines and which genes are involved.
- Pain medications Pharmacogenetics affects pain management on two fronts: how opioids are activated (or not) and how NSAIDs are cleared. The CYP2D6 gene is central to the opioid story because it converts … 13 drugs CYP2D6 CYP2C9
- Antipsychotics Antipsychotics treat schizophrenia, bipolar disorder, severe depression (as augmentation), and several other conditions. Modern antipsychotics mostly clear through CYP2D6 and CYP3A4, with smaller contributions from CYP1A2. Aripiprazole, brexpiprazole, iloperidone, and … 12 drugs CYP2D6 CYP1A2 CYP3A5
- Chemotherapy agents Pharmacogenetic testing in oncology is the most well-established and consequential part of clinical pharmacogenetics. Several chemotherapy drugs have mandatory or strongly recommended pre-treatment genetic testing because the toxicity difference between … 12 drugs DPYD TPMT UGT1A1
- Anesthesia and genetics Genetic differences can affect how your body responds to some medicines used during anesthesia. Two findings have different explanations: reduced BCHE enzyme activity can make certain muscle relaxants last longer, … 8 drugs BCHE RYR1 CACNA1S
- Tricyclic antidepressants Tricyclic antidepressants (TCAs) predate SSRIs and remain in use for depression, chronic pain, migraine prevention, and some sleep conditions. Nearly all TCAs are cleared by CYP2D6 and CYP2C19, often in … 7 drugs CYP2D6 CYP2C19
- Statins Statins are the mainstay of cholesterol management and cardiovascular disease prevention. They share a class-wide pharmacogenetic story: the SLCO1B1 transporter moves statins from blood into liver cells where they work. … 7 drugs SLCO1B1
- Other substances Pharmacogenetic effects on caffeine, alcohol, nicotine, cannabis, and several psychedelic compounds. The genes here (CYP1A2, ADH1B, ALDH2, CYP2A6, CYP2D6, COMT, FAAH) shape how strongly someone feels these substances and, in … 7 drugs CYP2D6 CYP1A2 ALDH2
- SSRI antidepressants SSRIs (selective serotonin reuptake inhibitors) are the most-prescribed antidepressant class, used for major depression, anxiety disorders, PTSD, OCD, and premenstrual dysphoric disorder. Most SSRIs are cleared by CYP2C19, CYP2D6, or … 6 drugs CYP2C19 CYP2D6
- Anticonvulsants Anticonvulsants treat epilepsy, bipolar disorder, trigeminal neuralgia, and neuropathic pain. The most consequential pharmacogenetic signal in this class is not about metabolism but about hypersensitivity: HLA-B*15:02 carriers have a dramatically … 4 drugs CYP2C9 CYP2C19
- Proton pump inhibitors Proton pump inhibitors (PPIs) are among the most prescribed drugs globally, used for GERD, peptic ulcer disease, and Helicobacter pylori eradication. Most PPIs are metabolized predominantly by CYP2C19. Rapid and … 4 drugs CYP2C19
- Immunosuppressants Immunosuppressants prevent organ rejection after transplant and control autoimmune conditions like lupus, inflammatory bowel disease, and rheumatoid arthritis. Pharmacogenetics is unusually critical in this class because the drugs have narrow … 4 drugs TPMT CYP3A5
- Antiemetics Antiemetics prevent nausea and vomiting in contexts like chemotherapy, post-operative recovery, and migraine. The clinically relevant pharmacogenetic signal in this class is CYP2D6 for ondansetron and its relatives. CYP2D6 ultrarapid … 4 drugs CYP2D6
- Antivirals The biggest pharmacogenetic story in antivirals is HLA-B*57:01 screening before abacavir, which essentially eliminated a previously common and sometimes fatal hypersensitivity reaction. This is one of the cleanest clinical wins … 3 drugs CYP2B6
- Movement disorder medications Medications for involuntary movement disorders (tardive dyskinesia, Huntington's disease chorea) work by depleting dopamine at nerve terminals. Several are metabolized by CYP2D6, which means poor metabolizers are at higher risk … 3 drugs CYP2D6
- Weight management (GLP-1 agonists) GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) are the dominant new drug class for weight management and type 2 diabetes. They all work the same way: activating incretin receptors slows gastric … 3 drugs GLP1R GIPR
- Gout treatment Allopurinol is the workhorse of chronic gout treatment. The pharmacogenetic angle Gene2Rx covers is ABCG2: reduced-function carriers respond less to allopurinol and often need higher doses or a switch to … 1 drug ABCG2
- Hair-loss medications Gene2Rx assesses SULT1A1 rs1042028, a functionally characterized variant that can reduce activity of the enzyme involved in activating topical minoxidil. This gives you a specific inherited finding to consider when … 1 drug SULT1A1